Will de Groot, MBA

Chief Business Officer

Mr. de Groot brings over 20 year of finance and biotechnology expertise to NKMax. Most recently, Will established an investment fund focused on memory care/assisted living. Previously, he was a Partner at a Boston-based Venture Capital Firm investing over $750 M for the biotech and healthcare technology space. Mr. de Groot spent the early part of his career in regulatory and commercial executive positions at Novartis, GSK and Millennium Pharmaceuticals/Takeda and holds an MBA from The University of Chicago Booth School of Business.  Mr. de Groot has guest lectured on the subject of venture investing and entrepreneurship at the University of California at Los AngelesCal State Los AngelesBoston University and the University of Chicago.